Recent studies show that patients with diabetes and prediabetes have a significantly higher prevalence of advanced liver fibrosis than previously recognized, with rates in primary care populations ranging from 9% to 15%.[4][5][6] The Fibrosis-4 (FIB-4) score is validated as the most accurate and accessible first-line tool for risk stratification in these groups, outperforming other non-invasive markers in identifying low-risk patients who can be safely managed in primary care and guiding when to refer patients to hepatology.[7][4][8][9] Systematic FIB-4 screening enables early detection and appropriate triage, helping prevent progression to cirrhosis and liver-related complications Why is FIB-4 screening important
LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, et al
"El entusiasmo por los resultados rpidos no puede atropellar la responsabilidad profesional
2023), exert neuroprotective effects by upregulating antioxidant enzymes (Devasagayam et al
Despite recent advancements in the understanding and management of lipedema, there remains a critical need for further research to establish standardized diagnostic criteria and targeted therapeutic strategies for this debilitating condition
beneficiaries who have an indication that is coverable under Part D will not be eligible for coverage under Bridge
